Oxford Centre for Haematology
The Oxford Centre for Haematology is a new initiative spanning the University of Oxford and the Oxford University Hospitals NHS Foundation Trust. It is a virtual centre bringing together researchers and clinicians working in haematology to improve the understanding and treatment of blood diseases and disorders, and to deliver the best available care to patients.
The OCH Management Board has as members the Director of the OCH, the Head of Clinical Haematology, the Head of Laboratory Haematology, the Head of the Radcliffe Department of Medicine, the Head of the Nuffield Division of Clinical Laboratory Sciences, the Director of the MRC Molecular Haematology Unit, the Director of the MRC Human Immunology Unit, the RDM Research Strategy Coordinator and the Administrator of the OCH.
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S. et al, (2017), Nat Commun, 8
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.
Giustacchini A. et al, (2017), Nat Med, 23, 692 - 702
Murphy MF. et al, (2017), Lancet Haematol, 4, e453 - e454
Sweeney C. et al, (2017), Haemophilia, 23, e451 - e453
Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.
Craddock CF. et al, (2017), Clin Cancer Res, 23, 6430 - 6440